Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit, Inc. reports developments tied to its national home health and hospice care business in the United States. The company’s Home Health segment provides Medicare-certified nursing, therapy, medical social work and aide services for adult patients, while its Hospice segment focuses on care for patients with life-limiting illnesses.
Recurring Enhabit news includes quarterly operating results, home health admissions and census trends, hospice performance, debt reduction and credit-related actions, investor presentations, material agreements, shareholder voting matters and governance updates. Company updates also cover legal and regulatory disclosures when they affect its public-company reporting or corporate matters.
Enhabit (NYSE: EHAB) set a special stockholder meeting for May 12, 2026 at 8:00 a.m. CDT to vote on the previously announced merger with affiliates of Kinderhook Industries. The company received early termination of the HSR waiting period on April 15, 2026, satisfying a closing condition.
The Merger is expected to close in Q2 2026 subject to remaining closing conditions and stockholder approval. Enhabit has suspended earnings calls, financial guidance, and does not intend to issue a Q2 2026 earnings release given the pending Merger.
Enhabit (NYSE: EHAB) reported Q4 2025 net service revenue of $270.4 million, an 4.7% increase year-over-year, with Adjusted EBITDA of $28.0 million (up 11.6% YoY) and a net loss attributable to Enhabit of $38.7 million. The company announced a definitive merger agreement to be acquired by Kinderhook for $13.80 per share and an amended credit facility totaling $475.0 million (term loan A $315.0M; revolver $160.0M) with maturity February 2031. Operationally, home health admissions grew 7.3% and hospice ADC grew 9.9%. Management suspended guidance given the pending transaction.
Enhabit (NYSE: EHAB)/b) agreed to be acquired by Kinderhook Industries for an . Stockholders will receive $13.80 per share in cash, a ~24.4% premium to the Feb 20, 2026 close. The deal is expected to close in Q2 2026, pending approvals; Enhabit will go private and continue operating under its brand.
Enhabit will not hold a Q4 2025 earnings call and will not issue 2026 guidance; Q4 and full‑year 2025 results are expected March 4, 2026 after market close.
Enhabit Home Health & Hospice (NYSE: EHAB) will report fourth-quarter and fiscal 2025 results on March 4, 2026 and host a webcast and conference call on March 5, 2026 at 9:00 a.m. EST.
Participants should join the webcast 15 minutes early. Call details: Toll-free 888-660-6150, International 929-203-0843, Conference ID 5248158. Webcast: https://events.q4inc.com/attendee/846254002. Enhabit operates 247 home health and 115 hospice locations across 34 states.
Enhabit (NYSE:EHAB) and Encompass Health (NYSE:EHC) collected $43.1 million in full satisfaction of claims for attorneys’ fees and mitigation damages from individual defendants in the Delaware Court of Chancery.
The December 2024 judgment found breaches of the duty of loyalty by named former officers; the court also placed a constructive trust granting Enhabit and Encompass Health a split of 43% of VitalCaring Group’s ongoing profits and exit proceeds if VitalCaring is sold. The settlement proceeds will be divided substantially equally between Enhabit and Encompass Health.
Enhabit (NYSE: EHAB) announced it will participate in the Bank of America Home Care Conference 2025. Enhabit President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will join a fireside chat on Tuesday, Dec. 9, 2025 at 2:50 p.m. CT.
The session will be webcast live at the provided Bank of America webcast URL, with a replay available within 24 hours. Both live and replay will also be accessible on Enhabit’s investor website under Events & Presentations.
Enhabit (NYSE: EHAB) reported Q3 2025 results for the quarter ended Sept. 30, 2025, with total net service revenue $263.6M, net income $11.1M, Adjusted EBITDA $27.0M, diluted EPS $0.22 and adjusted diluted EPS $0.17.
Key operational highlights: home health same-store admissions +3.6% and ADC +3.7% (Medicare ADC down 1.4%), hospice net service revenue +20.0% to $63.1M with hospice Adjusted EBITDA +72.0% and hospice ADC +12.6%. The company reduced bank debt by $15.0M in the quarter (7th straight quarter of prepayment) and reports a $100.0M reduction vs Q4 2023, yielding ~$19.2M annualized cash interest savings and a reported leverage of 3.9x.
Updated 2025 guidance: net service revenue $1,058–1,063M, Adjusted EBITDA $106–109M, Adjusted EPS $0.50–0.56.
Enhabit (NYSE: EHAB) will participate in the UBS Global Healthcare Conference 2025. Enhabit’s President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will appear in a fireside chat on Tuesday, Nov. 11, 2025 at 11:30 a.m. CT. The session will be webcast live and will be available for replay on Enhabit’s investor website.
Enhabit Home Health & Hospice (NYSE: EHAB) will report third-quarter 2025 results for the period ended Sept. 30, 2025 on Nov 5, 2025 and will host a webcast and conference call on Nov 6, 2025 at 9:00 a.m. ET.
Participants are asked to join 15 minutes early. Call numbers: Toll-free 888-660-6150, International 929-203-0843, Conference ID 5248158. Webcast: https://events.q4inc.com/attendee/991714917. A replay and webcast link will be available on Enhabit’s investor website.
Enhabit operates 249 home health locations and 114 hospice locations across 34 states. Investor contact: investorrelations@ehab.com.
Enhabit (NYSE:EHAB), a leading national home health and hospice provider, has announced its upcoming participation in the Jefferies 2025 Healthcare Services Conference. The company's President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will engage in a fireside chat on Tuesday, September 30, 2025, at 10:55 a.m. CT. Investors can access the live webcast and replay through Enhabit's investor website.